Trial ID or NCT#



not recruiting iconNOT RECRUITING


The primary purpose of this protocol is to assess the ExAblate 2100 MR guided high intensity focused ultrasound device as an intervention for treatment of facetogenic lower back pain.

Official Title

A Feasibility Study to Evaluate the Safety and Initial Effectiveness of MR Guided High Intensity Focused Ultrasound (MRgHIFU) in the Treatment of Facetogenic Lumbar Back Pain

Eligibility Criteria

Ages Eligible for Study: Older than 21 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No


Pejman Ghanouni, MD, PhD
Pejman Ghanouni, MD, PhD
Assistant Professor of Radiology (General Radiology) and, by courtesy, of Neurosurgery and of Urology at the Stanford University Medical Center
John Ratliff, MD, FACS
John Ratliff, MD, FACS
Spine neurosurgeon, Stereotactic neurosurgeon, Neuro-oncologist, Peripheral nerve surgeon
Professor of Neurosurgery and, by courtesy, of Orthopaedic Surgery at the Stanford University Medical Center

Contact us to find out if this trial is right for you.


Kara Richardson
(650) 561-5237